This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...
Both intravenous (IV) and intramuscular (IM) administration of the monoclonal antibody tixagevimab/cilgavimab rapidly eliminated culturable SARS-CoV-2, with both ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈